Carrier Screening Market Size, Share & Trends Report by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Carrier Screening Market Size Analysis

Global Carrier Screening Market Introduction
By Type
1. Introduction
  1. Type By Value
2. Expanded Carrier Screening
  1. By Value
3. Targeted Disease Carrier Screening
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. DNA Sequencing
  1. By Value
3. Polymerase Chain Reaction
  1. By Value
4. DNA Microarrays
  1. By Value
5. Others
  1. By Value
By Medical Condition
1. Introduction
  1. Medical Condition By Value
2. Pulmonary
  1. By Value
3. Hematology
  1. By Value
4. Neurology
  1. By Value
5. Rare Disease
  1. By Value
6. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Laboratories
  1. By Value
4. Physician Offices & Clinics
  1. By Value
5. Others
  1. By Value

North America Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Expanded Carrier Screening
  1. By Value
3. Targeted Disease Carrier Screening
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. DNA Sequencing
  1. By Value
3. Polymerase Chain Reaction
  1. By Value
4. DNA Microarrays
  1. By Value
5. Others
  1. By Value
By Medical Condition
1. Introduction
  1. Medical Condition By Value
2. Pulmonary
  1. By Value
3. Hematology
  1. By Value
4. Neurology
  1. By Value
5. Rare Disease
  1. By Value
6. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Laboratories
  1. By Value
4. Physician Offices & Clinics
  1. By Value
5. Others
  1. By Value
U.S.
1. By Type
  1. Introduction
    1. Type By Value
  2. Expanded Carrier Screening
    1. By Value
  3. Targeted Disease Carrier Screening
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. DNA Sequencing
    1. By Value
  3. Polymerase Chain Reaction
    1. By Value
  4. DNA Microarrays
    1. By Value
  5. Others
    1. By Value
3. By Medical Condition
  1. Introduction
    1. Medical Condition By Value
  2. Pulmonary
    1. By Value
  3. Hematology
    1. By Value
  4. Neurology
    1. By Value
  5. Rare Disease
    1. By Value
  6. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Laboratories
    1. By Value
  4. Physician Offices & Clinics
    1. By Value
  5. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Expanded Carrier Screening
  1. By Value
3. Targeted Disease Carrier Screening
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. DNA Sequencing
  1. By Value
3. Polymerase Chain Reaction
  1. By Value
4. DNA Microarrays
  1. By Value
5. Others
  1. By Value
By Medical Condition
1. Introduction
  1. Medical Condition By Value
2. Pulmonary
  1. By Value
3. Hematology
  1. By Value
4. Neurology
  1. By Value
5. Rare Disease
  1. By Value
6. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Laboratories
  1. By Value
4. Physician Offices & Clinics
  1. By Value
5. Others
  1. By Value
U.K.
1. By Type
  1. Introduction
    1. Type By Value
  2. Expanded Carrier Screening
    1. By Value
  3. Targeted Disease Carrier Screening
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. DNA Sequencing
    1. By Value
  3. Polymerase Chain Reaction
    1. By Value
  4. DNA Microarrays
    1. By Value
  5. Others
    1. By Value
3. By Medical Condition
  1. Introduction
    1. Medical Condition By Value
  2. Pulmonary
    1. By Value
  3. Hematology
    1. By Value
  4. Neurology
    1. By Value
  5. Rare Disease
    1. By Value
  6. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Laboratories
    1. By Value
  4. Physician Offices & Clinics
    1. By Value
  5. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Expanded Carrier Screening
  1. By Value
3. Targeted Disease Carrier Screening
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. DNA Sequencing
  1. By Value
3. Polymerase Chain Reaction
  1. By Value
4. DNA Microarrays
  1. By Value
5. Others
  1. By Value
By Medical Condition
1. Introduction
  1. Medical Condition By Value
2. Pulmonary
  1. By Value
3. Hematology
  1. By Value
4. Neurology
  1. By Value
5. Rare Disease
  1. By Value
6. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Laboratories
  1. By Value
4. Physician Offices & Clinics
  1. By Value
5. Others
  1. By Value
China
1. By Type
  1. Introduction
    1. Type By Value
  2. Expanded Carrier Screening
    1. By Value
  3. Targeted Disease Carrier Screening
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. DNA Sequencing
    1. By Value
  3. Polymerase Chain Reaction
    1. By Value
  4. DNA Microarrays
    1. By Value
  5. Others
    1. By Value
3. By Medical Condition
  1. Introduction
    1. Medical Condition By Value
  2. Pulmonary
    1. By Value
  3. Hematology
    1. By Value
  4. Neurology
    1. By Value
  5. Rare Disease
    1. By Value
  6. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Laboratories
    1. By Value
  4. Physician Offices & Clinics
    1. By Value
  5. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Expanded Carrier Screening
  1. By Value
3. Targeted Disease Carrier Screening
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. DNA Sequencing
  1. By Value
3. Polymerase Chain Reaction
  1. By Value
4. DNA Microarrays
  1. By Value
5. Others
  1. By Value
By Medical Condition
1. Introduction
  1. Medical Condition By Value
2. Pulmonary
  1. By Value
3. Hematology
  1. By Value
4. Neurology
  1. By Value
5. Rare Disease
  1. By Value
6. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Laboratories
  1. By Value
4. Physician Offices & Clinics
  1. By Value
5. Others
  1. By Value
UAE
1. By Type
  1. Introduction
    1. Type By Value
  2. Expanded Carrier Screening
    1. By Value
  3. Targeted Disease Carrier Screening
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. DNA Sequencing
    1. By Value
  3. Polymerase Chain Reaction
    1. By Value
  4. DNA Microarrays
    1. By Value
  5. Others
    1. By Value
3. By Medical Condition
  1. Introduction
    1. Medical Condition By Value
  2. Pulmonary
    1. By Value
  3. Hematology
    1. By Value
  4. Neurology
    1. By Value
  5. Rare Disease
    1. By Value
  6. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Laboratories
    1. By Value
  4. Physician Offices & Clinics
    1. By Value
  5. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Expanded Carrier Screening
  1. By Value
3. Targeted Disease Carrier Screening
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. DNA Sequencing
  1. By Value
3. Polymerase Chain Reaction
  1. By Value
4. DNA Microarrays
  1. By Value
5. Others
  1. By Value
By Medical Condition
1. Introduction
  1. Medical Condition By Value
2. Pulmonary
  1. By Value
3. Hematology
  1. By Value
4. Neurology
  1. By Value
5. Rare Disease
  1. By Value
6. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Laboratories
  1. By Value
4. Physician Offices & Clinics
  1. By Value
5. Others
  1. By Value
Brazil
1. By Type
  1. Introduction
    1. Type By Value
  2. Expanded Carrier Screening
    1. By Value
  3. Targeted Disease Carrier Screening
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. DNA Sequencing
    1. By Value
  3. Polymerase Chain Reaction
    1. By Value
  4. DNA Microarrays
    1. By Value
  5. Others
    1. By Value
3. By Medical Condition
  1. Introduction
    1. Medical Condition By Value
  2. Pulmonary
    1. By Value
  3. Hematology
    1. By Value
  4. Neurology
    1. By Value
  5. Rare Disease
    1. By Value
  6. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Laboratories
    1. By Value
  4. Physician Offices & Clinics
    1. By Value
  5. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Carrier Screening Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Natera, Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Illumina, Inc.
Myriad Genetics, Inc.
Thermo Fisher Scientific Inc.
Laboratory Corporation of America Holdings
Invitae Corporation
Fulgent Genetics, Inc.
Centogene N.V.
Quest Diagnostics Incorporated
Eurofins Scientific
BGI Genomics Co., Ltd.
Hoffmann-La Roche Ltd
Danaher Corporation
OPKO Health Inc.
PerkinElmer Inc.
MedGenome Inc.
Progenity Inc.
Others

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment